Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Terry

Showing results (591-600 of 698) with videos related to

Pageof 70
Sort By:
Obstetrics and Gynecology|April 8, 2016
Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma RiskAlice W Lee, Roberta B Ness, Lynda D Roman, et al.
Molecular Cancer Therapeutics|April 27, 2026
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the YoungAshleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
British Journal of Cancer|March 29, 2017
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association ConsortiumSuzanne C Dixon, Christina M Nagle, Nicolas Wentzensen, et al.
British Journal of Cancer|January 26, 2008
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysisC L Pearce, A H Wu, S A Gayther, et al.
International Journal of Epidemiology|December 7, 2017
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studiesLauren C Peres, Harvey Risch, Kathryn L Terry, et al.
International Journal of Epidemiology|March 28, 2018
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studiesLauren C Peres, Harvey Risch, Kathryn L Terry, et al.
International Journal of Epidemiology|April 10, 2013
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studiesWeiva Sieh, Shannon Salvador, Valerie McGuire, et al.
Journal of the National Cancer Institute|February 8, 2014
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association ConsortiumBritton Trabert, Roberta B Ness, Wei-Hsuan Lo-Ciganic, et al.
British Journal of Cancer|August 18, 2017
History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief reportAlbina N Minlikeeva, Jo L Freudenheim, Rikki A Cannioto, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 18, 2018
Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results from the EPIC CohortDaniel W Cramer, Raina N Fichorova, Kathryn L Terry, et al.
Pageof 70

Showing results (591-600 of 698) with videos related to

Sort By:
Pageof 70
Obstetrics and Gynecology|April 8, 2016
Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma RiskAlice W Lee, Roberta B Ness, Lynda D Roman, et al.
Molecular Cancer Therapeutics|April 27, 2026
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the YoungAshleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
British Journal of Cancer|March 29, 2017
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association ConsortiumSuzanne C Dixon, Christina M Nagle, Nicolas Wentzensen, et al.
British Journal of Cancer|January 26, 2008
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysisC L Pearce, A H Wu, S A Gayther, et al.
International Journal of Epidemiology|December 7, 2017
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studiesLauren C Peres, Harvey Risch, Kathryn L Terry, et al.
International Journal of Epidemiology|March 28, 2018
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studiesLauren C Peres, Harvey Risch, Kathryn L Terry, et al.
International Journal of Epidemiology|April 10, 2013
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studiesWeiva Sieh, Shannon Salvador, Valerie McGuire, et al.
Journal of the National Cancer Institute|February 8, 2014
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association ConsortiumBritton Trabert, Roberta B Ness, Wei-Hsuan Lo-Ciganic, et al.
British Journal of Cancer|August 18, 2017
History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief reportAlbina N Minlikeeva, Jo L Freudenheim, Rikki A Cannioto, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 18, 2018
Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results from the EPIC CohortDaniel W Cramer, Raina N Fichorova, Kathryn L Terry, et al.
Pageof 70